CH518364A - Verfahren zur Züchtung von gegenüber Schistosomen hochpathogenen Bakterien - Google Patents
Verfahren zur Züchtung von gegenüber Schistosomen hochpathogenen BakterienInfo
- Publication number
- CH518364A CH518364A CH495068A CH495068A CH518364A CH 518364 A CH518364 A CH 518364A CH 495068 A CH495068 A CH 495068A CH 495068 A CH495068 A CH 495068A CH 518364 A CH518364 A CH 518364A
- Authority
- CH
- Switzerland
- Prior art keywords
- bacteria
- schistosomes
- strain
- cultivation
- antiserum
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 201000004409 schistosomiasis Diseases 0.000 title abstract description 8
- 238000010253 intravenous injection Methods 0.000 title abstract description 7
- 239000007788 liquid Substances 0.000 title abstract description 4
- 241000242678 Schistosoma Species 0.000 claims abstract description 57
- 238000007912 intraperitoneal administration Methods 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 16
- 235000015097 nutrients Nutrition 0.000 claims description 13
- 241000588748 Klebsiella Species 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 12
- 230000003053 immunization Effects 0.000 claims description 8
- 238000001990 intravenous administration Methods 0.000 claims description 7
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 230000001717 pathogenic effect Effects 0.000 claims description 4
- 241000588921 Enterobacteriaceae Species 0.000 claims description 2
- 241000588722 Escherichia Species 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims description 2
- 241000607720 Serratia Species 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 4
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 abstract description 15
- 239000007924 injection Substances 0.000 abstract description 15
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 36
- 239000000725 suspension Substances 0.000 description 25
- 241000699666 Mus <mouse, genus> Species 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 238000010790 dilution Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 18
- 241000699800 Cricetinae Species 0.000 description 13
- 235000013601 eggs Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 230000007918 pathogenicity Effects 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 241000588747 Klebsiella pneumoniae Species 0.000 description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 238000011287 therapeutic dose Methods 0.000 description 4
- 241000237858 Gastropoda Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 235000019797 dipotassium phosphate Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 238000002817 Miles and Misra method Methods 0.000 description 2
- 241000242680 Schistosoma mansoni Species 0.000 description 2
- 241000011102 Thera Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000238008 Cerithidea rhizophorarum Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 101100043658 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ste11 gene Proteins 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- FAWGZAFXDJGWBB-UHFFFAOYSA-N antimony(3+) Chemical compound [Sb+3] FAWGZAFXDJGWBB-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007925 intracardiac injection Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/22—Klebsiella
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/42—Salmonella
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/425—Serratia
- C12R2001/43—Serratia marcescens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1534567 | 1967-04-04 | ||
| GB4837267 | 1967-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH518364A true CH518364A (de) | 1972-01-31 |
Family
ID=26251229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH495068A CH518364A (de) | 1967-04-04 | 1968-04-04 | Verfahren zur Züchtung von gegenüber Schistosomen hochpathogenen Bakterien |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE713147A (en:Method) |
| CA (1) | CA938223A (en:Method) |
| CH (1) | CH518364A (en:Method) |
| DE (1) | DE1767112A1 (en:Method) |
| DK (1) | DK128378B (en:Method) |
| FR (1) | FR8054M (en:Method) |
| IE (1) | IE31861B1 (en:Method) |
| IL (1) | IL29757A (en:Method) |
| NL (1) | NL6804680A (en:Method) |
| OA (1) | OA03358A (en:Method) |
-
1968
- 1968-04-02 DE DE19681767112 patent/DE1767112A1/de active Pending
- 1968-04-03 NL NL6804680A patent/NL6804680A/xx unknown
- 1968-04-03 DK DK146668AA patent/DK128378B/da unknown
- 1968-04-03 FR FR146812A patent/FR8054M/fr not_active Expired
- 1968-04-03 BE BE713147D patent/BE713147A/xx unknown
- 1968-04-03 IL IL29757A patent/IL29757A/xx unknown
- 1968-04-04 OA OA53243A patent/OA03358A/xx unknown
- 1968-04-04 IE IE392/68A patent/IE31861B1/xx unknown
- 1968-04-04 CA CA016715A patent/CA938223A/en not_active Expired
- 1968-04-04 CH CH495068A patent/CH518364A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE31861B1 (en) | 1973-01-24 |
| NL6804680A (en:Method) | 1968-10-07 |
| OA03358A (fr) | 1970-12-15 |
| IL29757A0 (en) | 1968-06-20 |
| IL29757A (en) | 1973-01-30 |
| BE713147A (en:Method) | 1968-10-03 |
| DE1767112A1 (de) | 1971-08-12 |
| DK128378B (da) | 1974-04-22 |
| IE31861L (en) | 1968-10-04 |
| CA938223A (en) | 1973-12-11 |
| FR8054M (en:Method) | 1970-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69132274T2 (de) | Methode der bakteriellen attenuierung und impfstoff | |
| DE4447677C2 (de) | Verfahren zur Herstellung eines Impfserums zur Immunisierung gegen Pseudomonas Aeruginosa-Infektionen | |
| DE2836507C2 (en:Method) | ||
| DE3853888T2 (de) | Verwendung von einem fructo-oligosaccharid zur herstellung einer bacteriostatischen zusammensetzung zur vorbeugung des wachsens von salmonellen und ein verfahren zur vorbeugung des wachsens von salmonellen. | |
| DE69316026T2 (de) | Als fischimpfstoff anwendbare attenuierte aeromonas salmonicida-stämme | |
| Stynes et al. | The production of toxin in annual ryegrass, Lolium rigidum, infected with a nematode, Anguina sp., and Corynebacterium rathayi | |
| DE2823346C2 (de) | Verwendung von Glycinderivaten zur Herstellung von antiviriellen Mitteln | |
| DE3011461C2 (de) | Verwendung von Propionibakterien | |
| DE2360118C3 (de) | Impfstoff gegen Ferkel-Colibacillose | |
| DE4104728C2 (de) | Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis | |
| EP0642796B1 (de) | Salmonella-Lebendimpfstoff | |
| DE1617397A1 (de) | Verfahren zur Herstellung eines tumorstatisch wirkenden Mittels | |
| DE2050945C3 (de) | Züchten lebensfähiger Staphylococcus-Bakterien zur Erzeugung einer Antivirus-Substanz | |
| DE2738652B2 (de) | Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen | |
| DE2854723C3 (de) | Hetero-Impfstoff zur therapeutischen Behandlung des Trichomonas -Syndroms und Verfahren zu seiner Herstellung | |
| CH518364A (de) | Verfahren zur Züchtung von gegenüber Schistosomen hochpathogenen Bakterien | |
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE841333C (de) | Verfahren zur Herstellung von Bakterienpraeparaten von Treponema Pallidum | |
| DE3118148A1 (de) | Antiallergisches praeparat und verfahren zu seiner herstellung | |
| DE2165401C3 (de) | Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane | |
| US3627877A (en) | Treatment of schistosomiasis in mammals | |
| DE338166C (de) | Verfahren zur Herstellung unschaedlicher Impfstoffe aus gifthaltigen pathogenen Mikroorganismen | |
| CH649709A5 (de) | Antitumor-praeparat und verfahren zu dessen herstellung. | |
| DE2805029C2 (de) | Impfstoff gegen virale hämorrhagische Sepsis von Forellen sowie Verfahren zu dessen Herstellung | |
| DE2437166C3 (de) | Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |